Home

LUIGI MD LENAZ

CIK 1193920 · Chief Scientific Officer · last filed 2018-05-22

LUIGI MD LENAZ is a Chief Scientific Officer who has filed 21 SEC Form 4 insider transactions across 1 company since 2007. The most recent filing shows the insider exercised options covering $58.8K of SPPI on May 22, 2018. Across all open-market trades the lifetime net is −$17.1K, making them a net seller over the disclosed history. 41 SEC filings were submitted jointly with SPECTRUM PHARMACEUTICALS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

21

Lifetime Open-Market Net

-$17.1K

Filer Profile

Reported Address
157 TECHNOLOGY DRIVE
IRVINE, CA 92618
Related Filers
SPECTRUM PHARMACEUTICALS INC — 41 joint filings, latest 2018-05-22
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Director 214,922 $1.03 $221.4K -$17.1K 21 2018-05-22

Recent Filings

21 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-05-22 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Exer (M) +40,000 $58.8K EDGAR
2017-06-29 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Tax (F) −625 -$4.7K EDGAR
2017-06-15 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Mixed +7,500 -$16.2K EDGAR
2016-06-29 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Mixed +6,875 -$19.9K EDGAR
2015-07-08 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Tax (F) −625 -$4.3K EDGAR
2015-07-01 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) +10,000 $0 EDGAR
2014-12-16 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Tax (F) −1,250 -$8.9K EDGAR
2014-07-01 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Mixed +9,375 -$5.0K EDGAR
2013-12-17 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Grant (A) +10,000 $0 EDGAR
2012-12-21 SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted Mixed +7,200 $81.6K EDGAR
Showing 1–10 of 21
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.